About Abella Frenchies
Our Team
At Abella Frenchies, our team is more than just a group of dog lovers. we’re a dedicated family of responsible breeders, passionate about the health, temperament, and future of the French Bulldog breed.
Each member of our small but experienced team brings years of hands-on experience in animal care, ethical breeding, and canine behaviour. We’re proudly based in New South Wales and are fully registered breeders, committed to upholding the highest standards in every aspect of our program.
We work closely with veterinary professionals, DNA testing services, and the MDBA DVL2 Elimination Program to ensure our French Bulldogs are not only beautiful and well-tempered, but also genetically sound. From birth to adoption, every pup is raised with love, care, and careful socialisation in a clean, enriching environment.
When you adopt from Abella Frenchies, you’re not just getting a puppy — you’re joining a community that genuinely cares. Our team is always here for advice, support, and a lifetime of tail wags.
About
Abella Frenchies
🧬 Understanding the DVL2 Gene in French Bulldogs
What is the DVL2 Gene?
The DVL2 gene, often referred to as the “screw tail gene,” is a recessive genetic variant associated with the distinctive curled or corkscrew tail seen in French Bulldogs. This gene is not merely a cosmetic trait; it has significant implications for the health and well-being of the breed.
Health Implications of the DVL2 Variant
Research has shown that the DVL2 variant is linked to several health issues in French Bulldogs:
• Hemivertebrae: Over 93% of French Bulldogs have malformed spinal vertebrae due to the DVL2 mutation, leading to potential mobility issues and discomfort.
• Brachycephalic Obstructive Airway Syndrome (BOAS): The gene contributes to the brachycephalic (short-muzzled) phenotype, exacerbating breathing difficulties common in the breed.
• Robinow-like Syndrome: The DVL2 mutation mirrors a human condition characterized by skeletal abnormalities, including shortened limbs and facial features.
• Other Health Concerns: Potential links to congenital heart defects, cleft palates, and even certain brain tumors have been observed, though further research is ongoing.
🛡️ MDBA’s Genetic Action Plan (GAP)
Purpose of the GAP
The Master Dog Breeders and Associates (MDBA) have implemented a Genetic Action Plan to proactively address and mitigate the health issues associated with the DVL2 gene in French Bulldogs. This plan emphasizes:
• Mandatory DNA Testing: All new adult French Bulldogs entering the MDBA registry after December 1, 2022, must be tested for the DVL2 and AdamTS3 genes.
• Informed Breeding Decisions: Breeders are encouraged to avoid mating two carriers of the DVL2 gene to prevent producing affected offspring.
• Data Collection and Analysis: The MDBA collects health data to monitor the prevalence of the DVL2 gene and assess the effectiveness of the GAP.
Success Stories
In April 2024, Chaleureux French Bulldogs became the first breeders to produce purebred French Bulldogs completely free of the DVL2 gene. This milestone demonstrates the effectiveness of the GAP and the commitment of responsible breeders to improve the breed’s health.
📊 Key Statistics
• Prevalence: The DVL2 gene is present in over 93% of French Bulldogs.
• Health Impact: French Bulldogs are significantly more prone to certain health issues compared to other breeds, including:
• Stenotic Nares: 42 times more prevalent.
• BOAS: 30 times more prevalent.
• Aural Discharge: 14 times more prevalent.
• Skin Fold Dermatitis: 11 times more prevalent.
• Dystocia: 9 times more prevalent.
🐾 Our Commitment
We are dedicated to the health and well-being of French Bulldogs. By adhering to the MDBA’s Genetic Action Plan and conducting thorough genetic testing, we aim to reduce the prevalence of the DVL2 gene and associated health issues in our breeding program.
